Minimal change disease relapse following SARS-CoV-2 mRNA vaccine

Kidney Int. 2021 Aug;100(2):457-458. doi: 10.1016/j.kint.2021.04.033. Epub 2021 May 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • COVID-19 Vaccines / adverse effects*
  • COVID-19* / prevention & control
  • Female
  • Humans
  • Nephrosis, Lipoid* / diagnosis
  • Recurrence
  • Vaccines, Synthetic / adverse effects*
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Vaccines, Synthetic